BioNTech – hat die arzneimittelrechtliche Erlaubnis zur Herstellung von Covid-19 Impfstoff in seinem Werk im hessischen Marburg erhalten

This entry was posted on Freitag, Januar 29th, 2021 at 09:09 and is filed under Administration, Healthcare Info. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

Leave a Reply

You must be logged in to post a comment.